The Laboratory for Computational Imaging and Bioinformatics (LCIB) at Rutgers, Hospital at University of Pennsylvania, and the Digital Pathology company, Bioimagene, have just signed a 3 year Xanax onlinesponsored research and licensing agreement to develop digital pathology image analysis algorithms for detection and grading of prostate cancer. Under this 3 year research agreement, Bioimagene will support Rutgers (PI: Anant Madabhushi) and UPENN (PI's: Michael Feldman, John Tomaszewski) with a $300,000 grant. Further, Bioimagene will sponsor a visiting scientist at LCIB and pathology fellow at UPENN, in addition to providing a commercial whole slide digital scanner and computational servers to the two academic institutions. Under this agreement, Bioimagene will license digital pathology algorithms developed at Rutgers and UPENN (Inventors: Anant Madabhushi, Scott Doyle, John Tomaszewski, Michael Feldman) for use in their commercial whole slide digital pathology scanners. Press release on CNBC: http://www.cnbc.com/id/34311051